QPPV.COM KNOWLEDGE ASSESSMENT

Knowledge Assessment: Respiratory Syncytial Virus Vaccine (Bivalent, Recombinant) Pharmacovigilance

Test your understanding of the concepts covered by Respiratory Syncytial Virus Vaccine (Bivalent, Recombinant): Biology, Maternal Immunisation and Pharmacovigilance.

Question 1 of 10Pass mark: 80%

Question 1 of 10 What is the principal immunological rationale for using stabilised prefusion F antigens in this vaccine?

They enable the vaccine to replicate briefly and generate mucosal immunity They preserve neutralisation-sensitive epitopes that are altered after F protein rearranges to its postfusion form They restrict the immune response to a single RSV antibody clone They eliminate the need for antigen presentation by immune cells

Question 2 of 10 Which example best demonstrates an inappropriate causal conclusion described in the article?

Following a GBS report with neurological examination and diagnostic testing Classifying an infant RSV hospitalisation as vaccine failure without laboratory confirmation, age at onset or maternal exposure details Comparing preterm-birth observations with appropriate background data Recording the gestational week at vaccination and delivery

Question 3 of 10 Which set of data is most relevant to evaluating a report of preterm birth after maternal vaccination?

Only the vaccine lot number and the infant's RSV test result Gestational age at vaccination and delivery, maternal risk factors, reason for delivery, neonatal outcome and relevant obstetric history Only whether the mother experienced injection-site pain The number of RSV cases in adults during the same month

Question 4 of 10 Why should neurological aggregate analyses preserve the interval between vaccination and symptom onset?

It permits evaluation of the relevant risk window rather than combining all lifetime GBS cases indiscriminately It proves that every case outside the window is unrelated to vaccination It removes the need for diagnostic confirmation It allows pregnancy outcomes to be analysed without denominators

Question 5 of 10 How should the pre-authorisation numerical imbalance in preterm births be handled in pharmacovigilance?

As definitive proof of a causal vaccine effect As evidence that preterm births should not be followed because the imbalance occurred before authorisation Through structured surveillance and comparison with appropriate background information, while recognising that causality was not established or excluded By counting only preterm births in vaccine recipients and excluding placebo recipients

Question 6 of 10 Why is recording only 'RSV vaccine' inadequate in a medication-error report?

Because all RSV vaccines are legally interchangeable and the description is unnecessarily detailed Because the generic description may not identify the antigen platform, adjuvant status, authorised population, formulation or relevant preparation requirements Because vaccine identity matters only for efficacy studies, not safety investigations Because the product name determines whether an adverse event is automatically serious

Question 7 of 10 Why are denominators and appropriate background data important in pregnancy surveillance?

They allow raw event counts to be interpreted in relation to the underlying frequency of the outcome They ensure that every pregnancy outcome is considered vaccine-related They replace the need to collect gestational age and maternal risk factors They are needed only for product-quality investigations

Question 8 of 10 Which statement best distinguishes adult vaccination from maternal vaccination?

Adult vaccination creates active immunity in the vaccinated adult, whereas maternal vaccination also enables passive antibody protection of the infant Adult vaccination protects only through transferred antibody, whereas maternal vaccination creates active infant immunity Both pathways directly vaccinate the infant, but only maternal vaccination requires intramuscular administration Maternal vaccination is intended to establish permanent active immunity in the infant

Question 9 of 10 In the context of this vaccine, what does 'bivalent' mean?

The vaccine contains two live RSV strains The vaccine provides protection only against two clinical manifestations of RSV disease The vaccine includes prefusion F antigens representing RSV subgroups A and B The vaccine produces exactly two types of antibody

Question 10 of 10 Which information is most important for reconstructing an RSV vaccine administration error?

Exact product and lot, intended population, preparation, route, dose, age or gestational context and clinical consequence Only the patient's name and the date the report was received Only whether the vaccine was administered in a hospital The patient's RSV antibody titre before the error, without details of administration

Knowledge Assessment: Respiratory Syncytial Virus Vaccine (Bivalent, Recombinant) Pharmacovigilance

Cookie Settings